Promising clinical activities support combination immunotherapy for metastatic kidney cancer
The results of an open-label pilot study by researchers at [...]
First patient dosed in the TiNivo clinical trial investigating a combination of tivozanib plus nivolumab
The first patient has been dosed in the TiNivo trial: [...]
NICE and NHS England plans to delay access to life-saving drugs
English charities warn that patients might have to wait three years [...]
Sign the petition to stop NHS and NICE plans that would delay access to vital new cancer treatments
We urgently need your help to stop plans that would [...]
Patient selection is key for kidney cancer treatments
There are now a number of treatment options available for [...]
Exercise better than drugs for cancer-related fatigue
A recent meta-analysis published in JAMA Oncology suggests that exercise and/or [...]
Savolitinib for papillary renal cell carcinoma
Papillary renal cell carcinoma (pRCC) is the second most common [...]
Durable response after stopping immunotherapy for kidney cancer
A recent study presented at the American Society for Clinical [...]
Vaccine trial for advanced kidney cancer recommended to be stopped
An independent data monitoring committee (IDMC) has recommended that the phase 3 [...]
Obesity linked to 11 cancer types, including kidney cancer
A study published in the British Medical Journal (BMJ) and [...]
